Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. The Company's subsidiary, Harvest Medicine provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by proneon Nov 19, 2022 9:43am
80 Views
Post# 35112450

RE:RE:Nice work Solid1 and thanks for bringing that info to

RE:RE:Nice work Solid1 and thanks for bringing that info to

President Joe Biden intends to sign a bipartisan marijuana research bill that was passed by Congress on Wednesday, a White House spokesperson confirmed to Marijuana Moment on Friday.

The Senate approved the legislation under unanimous consent this week, two months after it cleared the House. It represents the first piece of cannabis reform legislation in U.S. history to be transmitted to the president.

As Bloomberg first reported, Biden will sign the legislation, which would give the U.S. attorney general 60 days to either approve a given application or request supplemental information from the marijuana research applicant. It would also create a more efficient pathway for researchers who request larger quantities of cannabis.

Once the bill officially reaches Biden’s desk, he will have 10 days (excluding Sundays) to sign or veto it, otherwise it would take effect without his signature.

“Yes he’ll sign it,” a White House spokesperson told Marijuana Moment via email

<< Previous
Bullboard Posts
Next >>